What's breaking now, across thousands of outlets.
(RTTNews) - Australian biopharmaceutical company Immuron Ltd. (IMC.AX, IMRN), announced on Friday that it has signed an exclusive distribution deal with Sweden's Calmino group AB to launch its digestive health product PROIBS in the United States, following its rollout in Australi
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) — Nobel Resources Corp. (TSX – V: NBLC; OTCPK: NBTRF) (the “Company” or “Nobel”) announces that its annual and general special meeting of shareholders has been…
India’s unexpectedly strong economic growth has sparked a debate after an ex-bureaucrat questioned whether the expansion was overstated and a former central bank chief asked why strong expansion had…
TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) — Guardian Capital LP (the “Manager”) today announced that, as disclosed in the simplified prospectus dated May 21, 2025, GuardBonds™ 2026 Investment Grade…
Key PointsNuScale Power and Oklo are leading SMR stocks.
Gold (XAU/USD) moves quietly on Friday after two straight days of gains, as traders appear reluctant to take fresh positions ahead of the US Nonfarm Payrolls (NFP) report at 12:30 GMT.
